The Top Country With Most Scientists per Capita in the World
Rising Drug Costs Force a Third of Americans to Leave Prescriptions Unfilled: Report
Insulet Tops S&P 500 Growth Chart for Q2 as It Gains Market Share in the Diabetes Space
Cassava Sciences Shares Plunge on Indictment Against Former Advisor -- Barrons.com
Eli Lilly and Company (LLY): A Good Growth Stock To Buy Now According to Billionaire Ray Dalio
HIMS Stock Tumbles: Here's Why It's a Buy Right Now
Form 144 | Eli Lilly and Co(LLY.US) 10% Stockholder Proposes to Sell 195.44 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 28, $Eli Lilly and Co(LLY.US)$ 10% Stockholder LILLY ENDOWMENT INC intends to sell 215K shares of its common stock on Jun 28, with a total market value of approximately $19
Atossa Therapeutics Doubles Z-Endoxifen Dose in Phase 2 Breast Cancer Study
Insights Into Eli Lilly and Co's Performance Versus Peers In Pharmaceuticals Sector
Express News | Atossa Therapeutics: Change in Study Dose Was Determined Following a Review of Safety, Efficacy and Pharmacokinetic (Pk) Data
Dividend Roundup: Kroger, AT&T, Pfizer, JPMorgan, and More
Express News | EMA: Chmp Gave Positive Opinion for Tauvid (Flortaucipir (18F)), for Pet Imaging of the Brain
ResMed Stock Is Down Because of GLP-1 Concerns. It Shouldn't Be. -- Barrons.com
Him & Hers Down 6% Following Report on 'Shady Supplier' for Weight Loss Drug
Why is Eli Lilly and Co cooperating with OpenAI?
Eli Lilly and Co (LLY.US) is partnering with OpenAI, a ChatGPT manufacturer, to develop new therapies for combating drug-resistant diseases using artificial intelligence (AI).
Zhejiang Int'l Group (000411.SZ) has business collaborations with large pharmaceutical companies including Eli Lilly and Co, Novo-Nordisk A/S.
Zhejiang Int'l Group (000411.SZ) stated on the investor interaction platform on June 27th that the company is a pharmaceutical distribution enterprise mainly engaged in the wholesale and retail business of pharmaceuticals and medical instruments, and has business cooperation with large pharmaceutical enterprises including Eli Lilly and Co and Novo-Nordisk A/S. At present, the company operates tens of thousands of varieties and specifications of pharmaceutical products, including hypoglycemic products, but the sales of specific single variety and specification account for a small proportion of the company's overall sales. The company will continue to pay attention to newly launched drugs and actively carry out relevant introduction work.
Ben & Jerry's Co-Founders Not Worried About Ozempic's Impact On Ice Cream Business: Here's Why
How Consumer Spending, Election Impact Markets: Market Domination
Eli Lilly (LLY) Stock Drops Despite Market Gains: Important Facts to Note
Eli Lilly and Co(LLY.US) 10% Shareholder Sells US$170.01 Million in Common Stock